The Wu Zi Yan Zong pill, a traditional Chinese medicine, improves sperm quality by enhancing semen parameters and decreasing DNA damage in patients with oligoasthenozoospermia.
This research leverages a meta-analysis of five randomized, controlled trials involving 960 participants. These trials, found in databases from North-East Asian regions and scholarly platforms like PubMed, Embase, and Cochrane Library, focused on assessing the effect of Wuzi Yanzong pill on oligoasthenozoospermia. This investigation involved assessment of variables including sperm concentration, motility, morphology, the activity of acrosomal enzyme, volume of semen, and the sperm DNA fragmentation index.
Although the qualities of the selected studies were generally contentious and there was apparent heterogeneity in some of the outcomes, the researchers concluded that the Wuzi Yanzong pill had a positive impact. It demonstrated a significant potential for enhancing sperm quality in treatments for oligoasthenozoospermia. This was observed through improvements in multiple semen parameters, including an increase in sperm concentration and motility, as well as a decrease in DNA damage.
